Literature DB >> 2862901

Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.

B Silke, S P Verma, M A Frais, M Hafizullah, S H Taylor.   

Abstract

The action of nicardipine on cardiac volume, both at rest and during exercise-induced angina, was evaluated in 12 patients with angiographically-proven coronary artery disease. Nicardipine given to patients at rest reduced systemic vascular resistance and mean arterial pressure and increased heart rate and cardiac index. The left ventricular filling pressure, ejection fraction (EF), end-diastolic and end-systolic volumes were unchanged. During supine bicycle exercise, the reduction in systemic arterial blood pressure following nicardipine increased cardiac and stroke index and attenuated the rise in left ventricular filling pressure observed in the control exercise. The effects of nicardipine on EF, end-diastolic and end-systolic cardiac volumes were dependent on the baseline cardiac reserve. In patients with EF less than 50%, nicardipine improved EF and left ventricular exercise volumes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862901      PMCID: PMC1400779          DOI: 10.1111/j.1365-2125.1985.tb05161.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

Review 1.  Control of myocardial oxygen consumption: physiologic and clinical considerations.

Authors:  E Braunwald
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

2.  A hemodynamic study of acute coronary insufficiency precipitated by exercise. With observations on the effects of nitroglycerin.

Authors:  J O Parker; S Di Giorgi; R O West
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

3.  Noninvasive detection of left ventricular dysfunction with a portable electrocardiographic gated scintillation probe device.

Authors:  A Strashun; S F Horowitz; S J Goldsmith; L E Teichholz; A Dicker; K Miceli; R Gorlin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

4.  Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.

Authors:  B Silke; S P Verma; G I Nelson; M Hussain; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

Review 5.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease.

Authors:  C Y Chew; H S Hecht; J T Collett; R G McAllister; B N Singh
Journal:  Am J Cardiol       Date:  1981-04       Impact factor: 2.778

7.  Unpredictable response to nifedipine in severe cardiac failure.

Authors:  N Brooks; M Cattell; J Pidgeon; R Balcon
Journal:  Br Med J       Date:  1980-11-15

8.  Haemodynamic effects of nifedipine in heart failure.

Authors:  S Klugmann; A Salvi; F Camerini
Journal:  Br Heart J       Date:  1980-04

9.  Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging.

Authors:  G J Dehmer; M Falkoff; S E Lewis; L D Hillis; R W Parkey; J T Willerson
Journal:  Br Heart J       Date:  1981-06

10.  Effects of verapamil on myocardial performance in coronary disease.

Authors:  J Ferlinz; J L Easthope; W S Aronow
Journal:  Circulation       Date:  1979-02       Impact factor: 29.690

View more
  5 in total

Review 1.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 2.  Management of systemic and pulmonary hypertension.

Authors:  Jerrold H Levy
Journal:  Tex Heart Inst J       Date:  2005

3.  Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.

Authors:  B Silke; S P Verma; A V Zezulka; S Sharma; G Reynolds; N C Jackson; S Guy; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

4.  Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters.

Authors:  B Silke; S de la Motte; P Spiers; N A Herity; M Drake; J Kelly; F J Harrison
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 5.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.